Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Michael Saylor expects Bitcoin to grow 30% annually and plans a dividend-paying Bitcoin fund.

Market News
13 May 2026
Crypto Briefing
View Source
Bullish
pluang ai news

Michael Saylor, executive chairman of Strategy, predicts Bitcoin will appreciate about 30% per year for the next 20 years, potentially making today's price negligible by 2045. He proposed a Bitcoin capital gains fund that would pay dividends based on Bitcoin's price gains, aiming to attract income-focused investors by turning Bitcoin into a yield-generating asset. Strategy currently holds around 500,000 BTC, acquired through over $30 billion in fundraising since 2020, with plans to increase holdings by nearly 29% through new share issuance. This approach could further normalize corporate Bitcoin adoption but carries dilution risks if Bitcoin's price declines or stalls.

More News

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...

Company Fundamentals
Neutral
2 hours ago
Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...

Company Fundamentals
Neutral
2 hours ago
Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...

Market News
Neutral
2 hours ago
Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...

Market News
Neutral
2 hours ago
Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App